Hemera has been named co-winner of the 2024 IMSA – Italian Master Startup Award in the Life Sciences MED-Tech category, alongside ALBA Robot.
The award highlights the most promising and innovative startups in Italy. It is organized by the PNICube Association in collaboration with the Innovative Companies Incubator of the Politecnico di Torino (I3P), and under the patronage of the Ministry of Enterprises and Made in Italy, the Ministry of Foreign Affairs and International Cooperation, the Italian Embassy to the Holy See, and ASviS.
This recognition confirms the innovative value and significant clinical impact of REMaST in the emerging landscape of spinal cord injury treatment.